Compare Invesco India Pharma And Healthcare Fund vs ICICI Prudential Healthcare Fund
Invesco India Pharma And Healthcare Fund
EquitySectoral-Pharma
ICICI Prudential Healthcare Fund
EquitySectoral-Pharma
Risk
Very High
Very High
Rating
-
4.0
Min SIP Amount
₹100
₹100
Expense Ratio
5.19
2.07
NAV
₹9.07
₹44.81
Fund Started
18 Aug 2026
25 Jun 2018
Fund Size
₹435.52 Cr
₹6861.20 Cr
Exit Load
Exit load of 0.50%, if redeemed within 3 months.
Exit load of 1% if redeemed within 15 days.
1 Year
-
2.11%
3 Year
-
19.35%
5 Year
-
13.95%
Equity
87.01%
98.91%
Cash
12.99%
1.09%
Top 10 Holdings
Name | Assets |
|---|---|
Max Healthcare Institute Ltd. | 9.58% |
Sun Pharmaceutical Industries Ltd. | 8.99% |
Sai Life Sciences Ltd. | 8.63% |
Apollo Hospitals Enterprise Ltd. | 8.03% |
Manipal Health Enterprises Ltd. | 7.98% |
Divi's Laboratories Ltd. | 7.85% |
Global Health Ltd. | 7.00% |
Dr. Agarwal's Health Care Ltd. | 6.32% |
CORONA Remedies Ltd. | 6.13% |
Torrent Pharmaceuticals Ltd. | 4.93% |
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 11.49% |
Dr. Reddy's Laboratories Ltd. | 9.73% |
Cipla Ltd. | 5.79% |
Biocon Ltd. | 5.33% |
Mankind Pharma Ltd. | 5.04% |
Alkem Laboratories Ltd. | 4.81% |
Medplus Health Services Ltd. | 4.31% |
Cohance Lifesciences Ltd. | 4.06% |
Divi's Laboratories Ltd. | 3.78% |
Syngene International Ltd. | 3.50% |
Name
-
-
Start Date
-
-
Description
The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of the companies in Pharmaceuticals, Healthcare and allied sectors
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
Launch Date
18 Aug 2026
25 Jun 2018
